leisure time -WSS

leisure time

author：Wikipedia 2025-09-28 20:32:30 - browse：99251

Sarepta - Cambridge -AP — Kristoffer Tripplaar/Sipa via AP

To hear Sarepta CEO Doug Ingram tell it, the results Monday afternoon from a large trial of its gene therapy for Duchenne muscular dystrophy marked a clear medical breakthrough. “A massive win,” he told investors, that could lead to its approval for all patients with the fatal muscle-wasting disease regardless of age.

And yet the rest of the Duchenne community was more cautious in its enthusiasm. The study — the most rigorous test to date of a technology 30 years in the making — had technically failed, as so many had before it.

“It’s extremely frustrating,” said John Brandsema, a pediatric neurologist at Children’s Hospital of Philadelphia who worked on the study. “When you spend decades trying to bring therapies into the clinic for something so severe and just keep missing over and over again.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： Sana to lay off nearly a third of staff, de

knowledge

WSS

A Q&A with the global head of Boehringer Ingelheim's innovation unit

Watch the official trailer for 'Ahsoka' series

Phenylephrine and the overlooked value of the placebo effect

Watch the official trailer for 'Ahsoka' series

Is there an 'orca uprising'? Like orcas themselves, the answer is complex.

Chemotherapy drug shortage eases slightly but still widespread

focus

leisure time

leisure time

FDA approval of Sarepta Duchenne genetic therapy gives me hope

After half a century, Israel moves to evict squatter from his cave home on the beach

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Liquid biopsy for lung cancer is launched by Delfi

Medical leaders decry Supreme Court decision on affirmative action

A Greenpeace activist is fined for crash

Novavax promises a turnaround & Lilly roils the obesity market

3 questions for the future of Biden's cancer moonshot

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

How are insurers handling Leqembi and related scans?

explore

Tornado touches down near Chicago's O'Hare airport amid extreme weather nationwide

Histogen: Failed biotech offers rare public look inside

Tornado touches down near Chicago's O'Hare airport amid extreme weather nationwide

Colorectal cancer study finds potential in overlooked immune cell

Bill would stop addiction treatment from triggering child abuse inquiry

Analysis of telehealth claims data suggest service duplication

entertainment

focus

knowledge

Wikipedia